REQUEST A DEMO
Total
USD $0.00
Search more companies

Agencija Za Lekove I Medicinska Sredstva Srbije (Serbia)

Main Activities: Public Administration
Full name: Agencija Za Lekove I Medicinska Sredstva Srbije Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Agencija Za Lekove I Medicinska Sredstva Srbije is a company based in Serbia, with its head office in Belgrade. The enterprise currently operates in the Public Administration sector. Agencija Za Lekove I Medicinska Sredstva Srbije was incorporated on November 30, 2004. It currently has a total number of 233 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 10.19% in 2024. There was a total growth of 6.91% in Agencija Za Lekove I Medicinska Sredstva Srbije’s total assets over the same period. In 2024, Agencija Za Lekove I Medicinska Sredstva Srbije’s net profit margin decreased by 0.04%.

Headquarters
Vojvode Stepe 458 458
Belgrade; Belgrade;

Contact Details: Purchase the Agencija Za Lekove I Medicinska Sredstva Srbije report to view the information.

Website: http://www.alims.gov.rs

Basic Information
Total Employees:
Purchase the Agencija Za Lekove I Medicinska Sredstva Srbije report to view the information.
Registered Capital:
Purchase the Agencija Za Lekove I Medicinska Sredstva Srbije report to view the information.
Financial Auditors:
Purchase the Agencija Za Lekove I Medicinska Sredstva Srbije report to view the information.
Incorporation Date:
November 30, 2004
Company Performance
Financial values in the chart are available after Agencija Za Lekove I Medicinska Sredstva Srbije report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
10.19%
Total operating revenue
9.27%
Operating Profit/Loss (EBIT)
11.14%
EBITDA
9.15%
Net Profit/Loss for the Period
10.08%
Total Assets
6.91%
Total Equity
6.21%
Operating Profit Margin (ROS)
0.42%
Net Profit Margin
-0.04%
Return on Equity (ROE)
2.27%
Quick Ratio
0.03%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?